N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine атрибут
Температура плавления: |
157 - 162°C |
плотность: |
1?+-.0.06 g/cm3(Predicted) |
температура хранения: |
2-8°C(protect from light) |
растворимость: |
Водная кислота (Мало растворим), метанол (Мало растворим), вода (незначительно, нагретая) |
форма: |
Твердый |
пка: |
13.36±0.50(Predicted) |
цвет: |
От белого до не совсем белого |
InChI: |
InChI=1S/C13H19N5/c1-9-3-5-14-7-11(9)18(2)13-10-4-6-15-12(10)16-8-17-13/h4,6,8-9,11,14H,3,5,7H2,1-2H3,(H,15,16,17)/t9-,11+/m1/s1 |
ИнЧИКей: |
XRIARWQZLGCQDM-KOLCDFICSA-N |
SMILES: |
C1=NC(N(C)[C@@H]2[C@H](C)CCNC2)=C2C=CNC2=N1 |
FDA UNII: |
TD92PJW2H4 |
безопасность
- Заявления о рисках и безопасности
- код информации об опасности(GHS)
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine химические свойства, назначение, производство
Описание
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine is an important pharmaceutical intermediate that is a by-product of the preparation of tofacitinib. Tofacitinib belongs to a class of Janus kinase (JAK) inhibitors used in the treatment of rheumatoid arthritis and psoriatic arthritis.
Использование
N-Methyl-N-((3S,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, is an intermediate in the synthesis of (3S,4R)-Tofacitinib (T528010), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine препаратная продукция и сырье
сырьё
препарат
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine поставщик
Global( 196)Suppliers
477600-74-1()подобный поиск: